RPG Life Sciences Ltd.

NSE: RPGLIFE | BSE: 532983

₹2,632.10

up-down-arrow ₹129.60 (5.18%)

As on 19-Nov-2026 13:34IST

Market cap

info icon

₹4,325 Cr

Revenue (TTM)

info icon

₹764 Cr

P/E Ratio

info icon

39.5

P/B Ratio

info icon

6.3

Div. Yield

info icon

0.9 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score9/10

Growth Score fund-quick-summary-circle

Growth Score5/10

Valuation Score fund-quick-summary-circle

Valuation Score4/10

Momentum Score fund-quick-summary-circle

Momentum Score8/10

RPG Life Sciences Share Price

Compare

High: Low: Return:

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 2,460.10 High: 2,650.00

52 Week Range

Low: 1,733.00 High: 3,127.80

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹109 Cr

  • ROEROE information

    20.3 %

  • ROCEROCE information

    27 %

  • Industry P/EIndustry P/E information

    40.53

  • EV/EBITDAEV/EBITDA information

    23.3

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹415.5

  • EPSEPS information

    ₹69.5

  • Face valueFace value information

    8

  • Shares outstandingShares outstanding information

    16,539,015

10 Years Aggregate

CFO

₹560.52 Cr

EBITDA

₹857.56 Cr

Net Profit

₹610.55 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
RPG Life Sciences
13.3 -10.5 -2.6 14.4 21.3 33.4 19.1
BSE Healthcare
21.7 9.5 4.0 18.7 21.5 16.0 13.3
As on 19-Nov-2026
Company
2025
2024
2023
2022
2021
2020
2019
RPG Life Sciences
5.7 63.9 57.7 37.0 64.6 15.8 30.6
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
RPG Life Sciences
2,632.1 4,325.0 764.3 111.0 17.3 17.8 39.5 6.3
1,447.8 17,793.4 2,684.4 669.7 31.3 19.8 26.6 4.9
518.1 9,726.9 1,095.9 285.3 28.2 15.6 34.1 4.2
553.2 11,562.2 1,170.4 279.6 28.2 13.9 40.9 5.5
2,347.6 44,920.6 10,234.1 1,092.7 16.2 21.6 41.1 8.4
191.9 5,635.7 2,751.1 203.2 10.1 11.4 27.7 2.9
21,111.0 27,154.5 2,307.2 452.6 26.0 23.2 60 13.4
1,208.0 13,818.1 709.6 188.6 32.9 20.5 73.4 14.4
268.9 7,589.6 9.1 -382.1 -4,451.2 -73.1 -- 16.7
1,608.6 10,257.2 869.2 109.9 -- 11.2 93.3 7.5

Shareholding Pattern

View Details
loading...

News & Analysis

All News

No Review & Analysis are available.

About RPG Life Sciences

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs...  in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust. 

  • Incorporated

    2007

  • Chairman

    Harsh Goenka

  • Managing Director

    Ashok Nair

  • Group

    RPG Enterprises

  • Headquarters

    Mumbai, Maharashtra

  • Website

    www.rpglifesciences.com

FAQs for RPG Life Sciences

The share price of RPG Life Sciences Ltd is ₹2,632.10 (NSE) and ₹2,632.10 (BSE) as of 19-Nov-2026 13:34 IST. RPG Life Sciences Ltd has given a return of 21.34% in the last 3 years.

The P/E ratio of RPG Life Sciences Ltd is 39.54 times as on 19-Nov-2026, a 2 discount to its peers’ median range of 40.53 times.
The P/B ratio of RPG Life Sciences Ltd is 6.29 times as on 19-Nov-2026, a 72 premium to its peers’ median range of 3.66 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
26.57
5.05
2025
20.56
7.10
2024
28.87
6.75
2023
17.01
3.74
2022
17.98
3.62

The 52-week high and low of RPG Life Sciences Ltd are Rs 3,127.80 and Rs 1,733.00 as of 19-Nov-2026.

RPG Life Sciences Ltd has a market capitalisation of ₹ 4,325 Cr as on 19-Nov-2026. As per SEBI classification, it is a Small Cap company.

Before investing in RPG Life Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month